AI harnessed for early identification of cardiovascular problems
Cardiovascular disease is the world’s biggest killer, responsible for almost 18m deaths a year, according to the World Health Organization. But what if your likelihood of suffering from heart disease could be identified a decade in advance, enabling you to take preventive measures?
That is the promise of new medical imaging developed at the University of Oxford that received EU approval in 2021 and has begun to be used at several hospitals in the UK. The technology, CaRi-Heart, detects normally invisible signs of inflammation around coronary arteries from routine heart scans and uses artificial intelligence to identify the problems that could cause a heart attack.
You can read the full article via the Financial Times.
Read more
April 2024
Surrey Cardiovascular Clinic and Caristo Diagnostics Launch Employee Heart Wellness and Disease Prevention Program for UK Employers
Caristo’s AI technology predicts heart attack risk for employee wellness initiative from respected centre of excellence OXFORD, England and SURREY, England , April 23,…
Read more
April 2024
American College of Cardiology Presentation Highlights Promising Results Showing Potential to Reduce Coronary Inflammation with Abcentra’s Orticumab
Caristo’s CaRi-Heart® AI Technology used to monitor effects of Orticumab detected a reduction in coronary inflammation and predicted a 50%…